Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2008
07/16/2008EP1944303A1 Pyridine derivative substituted by heterocycle and fungicide containing the same
07/16/2008EP1944024A1 O-substituted aniline derivative and antioxidant drug
07/16/2008EP1943245A2 1,3-disubstituted indole derivatives for use as ppar modulators
07/16/2008EP1943222A1 Antibacterial active 5-chinolin derivative
07/16/2008EP1943220A2 Novel indole-containing beta agonists, method for producing them and their use as drugs
07/16/2008EP1943215A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
07/16/2008EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
07/16/2008EP1942899A2 Mitotic kinesin inhibitors
07/16/2008EP1942890A2 Chemokine receptor binding compounds
07/16/2008EP1709044B1 Oxazolidinone-quinolone hybrid antibiotics
07/16/2008EP1581492B1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
07/16/2008EP1527049B1 Fused heterocyclic compounds as peptidase inhibitors
07/16/2008EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
07/16/2008CN101223165A Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide
07/16/2008CN101223164A Substituted piperidines as renin inhibitors
07/16/2008CN101223157A Methods for synthesizing heterocyclic compounds
07/16/2008CN101223140A Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity
07/16/2008CN101222924A Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
07/16/2008CN101220023A Coordination polymer type ion exchange material, preparation and application thereof
07/16/2008CN101220002A Oxazolidinone compound as antimicrobial
07/16/2008CN101220000A Acyl chloride and sulfonyl chloride derivant, and uses thereof
07/16/2008CN100402525C Pyridine derivatives as fungicidal compounds
07/16/2008CN100402523C Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/16/2008CN100402032C Tetrahydroquinoline analogues as muscarinic agonists
07/15/2008US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
07/15/2008US7399865 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes
07/15/2008US7399781 N-substituted benzothiophenesulfonamide derivatives
07/15/2008US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease
07/15/2008US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists
07/15/2008US7399777 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
07/15/2008US7399773 Intermediates in the synthesis of atorvastatin calcium (Lipitor (reg)), 5-(4-fluorophenyl)-2-isopropyl-1-(4-(morpholinocarbonylmethylcarbonyl)-2-hydroxybutyl)-4-phenyl-3-(N-phenylcarbamoyl)-1H-pyrrole for example
07/15/2008US7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
07/15/2008US7399765 Substituted diazabicycloalkane derivatives
07/15/2008CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
07/15/2008CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors
07/10/2008WO2008083354A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/10/2008WO2008082637A1 Composition and methods for modulating a kinase cascade
07/10/2008WO2008082487A2 Novel jnk inhibitors
07/10/2008WO2008081537A1 Aromatic amino acid derivative with lat1 inhibitory activity, lat1 inhibitor containing the same and method for producing the same
07/10/2008WO2008081475A2 Novel crystalline forms of zolmitriptan
07/10/2008WO2008081247A2 A process for the preparation of secotaxanes
07/10/2008WO2008081208A1 Piperidine gpcr agonists
07/10/2008WO2008081207A1 Piperidine gpcr agonists
07/10/2008WO2008081206A1 Piperidine gpcr agonists
07/10/2008WO2008081205A1 Piperidine gpcr agonists
07/10/2008WO2008081204A1 Piperidine gpcr agonists
07/10/2008WO2008080891A2 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
07/10/2008WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
07/10/2008WO2008080455A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein
07/10/2008WO2008058867A3 Substituted 4-imidazoles
07/10/2008WO2008048991A3 Organic compounds
07/10/2008WO2008022046B1 Dicer substrate rna peptide conjugates and methods for rna therapeutics
07/10/2008WO2006050057A3 Methods and compositions using pde4 modulators for treatment and management of central nervous system injury
07/10/2008US20080167466 Capped pyrazinoylguanidine sodium channel blockers
07/10/2008US20080167354 Treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid
07/10/2008US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders
07/10/2008US20080167308 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
07/10/2008US20080167305 Sodium channel moderators; antiarrhythmia agents; cardiovascular disorders; antiinflammatory agents; analgesics; antiarthritic agents; nervous system disorders; antiepileptic agents; psychological disorders;multiple sclerosis; irritable bowel syndrome
07/10/2008US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors
07/10/2008US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases
07/10/2008US20080167299 menopause therapy; contraceptive; anticancer agents
07/10/2008US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases
07/10/2008US20080167286 Pharmaceutical compositions and their methods of use
07/10/2008US20080166362 New effector conjugates, process for their production and their pharmaceutical use
07/10/2008CA2710046A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/10/2008CA2674455A1 Piperidine gpcr agonists
07/10/2008CA2674360A1 Piperidine gpcr agonists
07/10/2008CA2674355A1 Piperidine gpcr agonists
07/10/2008CA2674348A1 Piperidine gpcr agonists
07/10/2008CA2674168A1 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
07/10/2008CA2674093A1 Piperidine gpcr agonists
07/10/2008CA2673974A1 Composition and methods for modulating a kinase cascade
07/10/2008CA2673428A1 Tetrahydrobenzoisoxazole and tetrahydroindazole derivatives as modulators of the mitotic motor protein
07/10/2008CA2673238A1 A process for the preparation of secotaxanes
07/10/2008CA2672940A1 Novel jnk inhibitors
07/09/2008EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
07/09/2008EP1941881A1 Dermatitis remedies
07/09/2008EP1940831A1 Salicylate and gentisate salts of a piperazine compound
07/09/2008EP1940830A1 Glucuronate salt of a piperazine compound
07/09/2008EP1940829A2 Imidazole derivatives and their use for modulating the gabaa receptor complex
07/09/2008EP1940805A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
07/09/2008EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers
07/09/2008EP1940401A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
07/09/2008EP1940393A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/09/2008EP1768978B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
07/09/2008EP1594853B1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
07/09/2008EP1578744B1 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
07/09/2008EP1539136B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
07/09/2008EP1455756B1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
07/09/2008EP1332133B1 Metabotropic glutamate receptor antagonists
07/09/2008EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
07/09/2008EP1276729B1 New neurokinin antagonists for use as medicaments
07/09/2008EP1220842B1 Cyclic amine compound as ccr5 antagonist
07/09/2008EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
07/09/2008CN101218235A Bicyclic derivatives as modulators of ion channels
07/09/2008CN101218234A Phenyl-3-{(3-(1H-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors
07/09/2008CN101218233A PPARalpha/gamma agonists and processes of preparing
07/09/2008CN101218232A Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
07/09/2008CN101218231A Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors